Eric Shaff, Seres Therapeutics CEO
To pay off debt and stay open, Seres will sell microbiome pill to partner Nestlé
Seres Therapeutics has signed an agreement with its commercialization partner Nestlé Health Science to sell the remaining rights to its microbiome pill and focus on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
